|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tungsten | CAS 7440-33-7 | ||
| W | RTECS YO7175000 | ||
|
Synonyms & Trade Names Tungsten metal, Wolfram |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL*: TWA 5 mg/m3 ST 10 mg/m3 [*Note: The REL also applies to other insoluble tungsten compounds (as W).] | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Hard, brittle, steel-gray to tin-white solid. |
|||
|
MW: 183.9 |
BP: 10,701°F |
MLT: 6170°F |
Sol: Insoluble |
|
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 19.3 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Combustible in the form of finely divided powder; may ignite spontaneously. | |||
|
Incompatibilities & Reactivities Bromine trifluoride, chlorine trifluoride, fluorine, iodine pentafluoride |
|||
|
Measurement Methods NIOSH 7074, 7300; OSHA ID213 |
|
Personal Protection & Sanitation Skin: No recommendation Eyes: No recommendation Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Fresh air Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH Up to 50 mg/m3: (APF = 10) Any air-purifying respirator with a high-efficiency particulate filter/(APF = 10) Any supplied-air respirator/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 10) Any air-purifying respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, respiratory system; diffuse pulmonary fibrosis; loss of appetite, nausea, cough; blood changes | |
|
Target Organs
Eyes, skin, respiratory system, blood |
|
| See also: INTRODUCTION |